<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="013488-2018"
            EDITION="2018008">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-013606-001</RECEPTION_ID>
      <DELETION_DATE>20180420</DELETION_DATE>
      <FORM_LG_LIST>FR </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>8</NO_OJ>
         <DATE_PUB>20180112</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 008-013488</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:013488-2018:TEXT:FR:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>FR</LG_ORIG>
         <ISO_COUNTRY VALUE="FR"/>
         <IA_URL_GENERAL>http://www.chu-nantes.fr</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33651520">Immunoglobulins</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="FRG01">Loire-Atlantique</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="FRG01">Loire-Atlantique</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="FR">FRANCE</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">18745161.36</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 186-380449</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180110</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Фpaнция</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Имуноглобулини</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Francie</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Imunoglobuliny</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Frankrig</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobuliner</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Frankreich</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunglobuline</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γαλλία</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Ανοσοσφαιρίνες</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobulins</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Inmunoglobulinas</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Prantsusmaa</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immuunglobuliinid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Ranska</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobuliinit</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobulines</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Fhrainc, an</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobulins</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Francuska</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Imunoglobini</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Franciaország</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunglobulin</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobuline</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Prancūzija</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Imunoglobulinai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Imūnglobulīni</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Franza</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobulini</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Frankrijk</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobulinen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Francja</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Immunoglobuliny</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>França</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Imunoglobulinas</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Franţa</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Imunoglobuline</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Francúzsko</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Imunoglobulíny</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Imunoglobulini</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Frankrike</TI_CY>
            <TI_TOWN>Nantes</TI_TOWN>
            <TI_TEXT>
               <P>Antikroppar</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="FR">CHU de Nantes</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="FR">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>CHU de Nantes</OFFICIALNAME>
               <ADDRESS>5 allée de l'Île Gloriette</ADDRESS>
               <TOWN>Nantes Cedex</TOWN>
               <POSTAL_CODE>44093</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <E_MAIL>bureau.desmarches@chu-nantes.fr</E_MAIL>
               <n2016:NUTS CODE="FRG01"/>
               <URL_GENERAL>http://www.chu-nantes.fr</URL_GENERAL>
               <URL_BUYER>https://www.marches-publics.gouv.fr</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Fourniture de médicaments dérivés du sang pour les besoins du CHU de Nantes</P>
            </TITLE>
            <REFERENCE_NUMBER>AOO-17078</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33651520"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Fourniture de médicaments dérivés du sang pour les besoins du CHU de Nantes.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">18745161.36</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33651520"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG01"/>
               <MAIN_SITE>
                  <P>CHU de Nantes 44093 Nantes.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Immunoglobulines polyvalentes humaines IV 100 mg/ml (10%) sans saccharose — Forme liquide.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Critères techniques</AC_CRITERION>
                  <AC_WEIGHTING>80</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Critères économiques</AC_CRITERION>
                  <AC_WEIGHTING>20</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33651520"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG01"/>
               <MAIN_SITE>
                  <P>CHU de Nantes 44093 Nantes.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Albumine plasmatique humaine 20%.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Critères techniques</AC_CRITERION>
                  <AC_WEIGHTING>80</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Critères économiques</AC_CRITERION>
                  <AC_WEIGHTING>20</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 186-380449</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>17-0574</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Lot 1 (1<FT TYPE="SUP">ère</FT> intention)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-02</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Octapharma France SAS</OFFICIALNAME>
                     <ADDRESS>62bis avenue André Morizet</ADDRESS>
                     <TOWN>Boulogne Billancourt</TOWN>
                     <POSTAL_CODE>92100</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">6248387.12</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>17-0575</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Lot 1 (2<FT TYPE="SUP">ème</FT> intention)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>CSL Behring SA</OFFICIALNAME>
                     <ADDRESS>7/11 Quai André Citroën — Tour Cristal</ADDRESS>
                     <TOWN>Paris</TOWN>
                     <POSTAL_CODE>75015</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">6248387.12</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>17-0576</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Lot 1 (3<FT TYPE="SUP">ème</FT> intention)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-01-02</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>SHIRE France SAS</OFFICIALNAME>
                     <ADDRESS>112 avenue Kleber</ADDRESS>
                     <TOWN>Paris</TOWN>
                     <POSTAL_CODE>75116</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">6248387.12</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>Le marché public est consultable dans le respect des secrets protégés par la loi sur demande écrite adressée au pouvoir adjudicateur dont les coordonnées sont mentionnées à la section I du présent avis. Le marché est conclu à compter du 1.1.2018 (ou sa date de notification si postérieur) jusqu'au 31.12.2018, reconductible 1 fois, soit jusqu'au 31.12.2019. Pour le lot n<FT TYPE="SUP">o </FT>1, l'accord-cadre à émission de bons de commandes est multi attributaires en application de l'article 78 du décret n<FT TYPE="SUP">o </FT>2016-360. Le nombre d'opérateurs économiques pouvant être retenus était fixé à 3. Le classement des attributaires pour chaque lot est précisé dans la section V. Il est conclu avec des quantités minimum et maximum annuelles. Le lot n<FT TYPE="SUP">o </FT>2 est déclaré sans suite car aucune offre n'a été reçue et le besoin est déjà pourvu via un marché passé avec l'opérateur national UNIHA.</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Tribunal Administratif de Nantes</OFFICIALNAME>
               <ADDRESS>6 allée de l'Île Gloriette</ADDRESS>
               <TOWN>Nantes Cedex</TOWN>
               <POSTAL_CODE>44041</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 240994600</PHONE>
               <E_MAIL>greffe.ta-nantes@juradm.fr</E_MAIL>
               <FAX>+33 240994658</FAX>
               <URL>http://nantes.tribunal-administratif.fr</URL>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>Référé contractuel (art. L 551-13 et s. du Cja) Recours en contestation de validité du contrat issu de la jurisprudence «Tarn et Garonne».</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-01-10</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
